Literature DB >> 826152

The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer.

E Bone, A Tamm, M Hill.   

Abstract

Epidemiological evidence is presented to relate the amount of dietary meat to the risk of large bowel cancer; it has been suggested that this may be due to the production of cocarcinogenic volatile phenols by intestinal bacteria from tyrosine. This paper describes preliminary experiments to test this suggestion. In vitro, aerobic bacteria tended to produce phenol from tyrosine while anaerobic bacteria produced p-cresol. Urine from 10 normal healthy persons contained a mean of 9.8 mg phenol/day and 51.8 mg p-cresol/day. Results from studies on patients with ileostomy, colostomy, and diverticular disease indicated that p-cresol is largely produced by the anaerobic flora of the left colon while phenol was produced in the ileum (when colonized) and cecum. In patients with familial polyposis the activity of the aerobic flora was apparently normal but there was greatly reduced amounts of p-cresol produced. The amounts of urinary volatile phenols in six patients with newly diagnosed large bowel cancer were not different from the normal values, indicating that cocarcinogenic phenols were unlikely to be a major cause of the disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 826152     DOI: 10.1093/ajcn/29.12.1448

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  47 in total

1.  Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites.

Authors:  William R Wikoff; Andrew T Anfora; Jun Liu; Peter G Schultz; Scott A Lesley; Eric C Peters; Gary Siuzdak
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

2.  Radiation metabolomics. 3. Biomarker discovery in the urine of gamma-irradiated rats using a simplified metabolomics protocol of gas chromatography-mass spectrometry combined with random forests machine learning algorithm.

Authors:  Christian Lanz; Andrew D Patterson; Josef Slavík; Kristopher W Krausz; Monika Ledermann; Frank J Gonzalez; Jeffrey R Idle
Journal:  Radiat Res       Date:  2009-08       Impact factor: 2.841

3.  Colonic contribution to uremic solutes.

Authors:  Pavel A Aronov; Frank J-G Luo; Natalie S Plummer; Zhe Quan; Susan Holmes; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

4.  Gas chromatographic identification of Clostridium difficile and detection of cytotoxin from a modified selective medium.

Authors:  P N Levett; K D Phillips
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

5.  Nanomolar Responsiveness of an Anaerobic Degradation Specialist to Alkylphenol Pollutants.

Authors:  Jannes Vagts; Arne Weiten; Sabine Scheve; Kristin Kalvelage; Sebastian Swirski; Lars Wöhlbrand; John Neidhardt; Michael Winklhofer; Ralf Rabus
Journal:  J Bacteriol       Date:  2020-02-11       Impact factor: 3.490

6.  Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare).

Authors:  David B Liesenfeld; Nina Habermann; Reka Toth; Robert W Owen; Eva Frei; Jürgen Staffa; Petra Schrotz-King; Karel D Klika; Cornelia M Ulrich
Journal:  Metabolomics       Date:  2014-12-20       Impact factor: 4.290

Review 7.  The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism.

Authors:  George E Jaskiw; Mark E Obrenovich; Curtis J Donskey
Journal:  Psychopharmacology (Berl)       Date:  2019-06-13       Impact factor: 4.530

Review 8.  Low-dose metabolism of benzene in humans: science and obfuscation.

Authors:  Stephen M Rappaport; Sungkyoon Kim; Reuben Thomas; Brent A Johnson; Frederic Y Bois; Lawrence L Kupper
Journal:  Carcinogenesis       Date:  2012-12-07       Impact factor: 4.944

Review 9.  The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism.

Authors:  Peter Spanogiannopoulos; Elizabeth N Bess; Rachel N Carmody; Peter J Turnbaugh
Journal:  Nat Rev Microbiol       Date:  2016-03-14       Impact factor: 60.633

Review 10.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.